N,N-Dimethyl-N'-(dimethylamino-methoxymethyl)-formamidin

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 原羧酸衍生物
• 英文名称: N,N-Dimethyl-N'-(dimethylamino-methoxymethyl)-formamidin
• 英文别名: N'-[dimethylamino(methoxy)methyl]-N,N-dimethylmethanimidamide
• 化学式: C₇H₁₇N₃O
• 分子量: 159.231
• InChiKey: XDZNTRNGGFGSQT-SOFGYWHQSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0
• 重原子数：
  11
• 可旋转键数：
  4
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.86
• 拓扑面积：
  28.1
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  N,N-Dimethyl-N'-(dimethylamino-methoxymethyl)-formamidin 在 硫化氢 作用下， 以 环己烷 为溶剂， 以92%的产率得到N,N-二甲基硫代甲酰胺
  参考文献：
  名称：

  Kantlehner, Willi; Hauber, Michael; Haug, Erwin, Journal fur Praktische Chemie (Weinheim), 2000, vol. 342, # 7, p. 682 - 699

  摘要：

  DOI：

文献信息

• PYRAZOLOQUINOLINE COMPOUND
  申请人：ASTELLAS PHARMA INC.

  公开号：US20130225553A1

  公开（公告）日：2013-08-29

  The present inventors have investigated a compound which has a PDE9-inhibiting action and is useful as an active ingredient for an agent for treating and/or preventing storage dysfunction, voiding dysfunction, bladder/urethral diseases, and the like, and thus, have found that a pyrazoloquinoline compound has a PDE9-inhibiting action, thereby completing the present invention.

  本发明者已经研究了一种具有PDE9抑制作用的化合物，并且可用作治疗和/或预防储存功能障碍，排尿功能障碍，膀胱/尿道疾病等制剂的活性成分。因此，发现一种吡唑喹啉化合物具有PDE9抑制作用，从而完成了本发明。
• Orthoamide. IL. Umsetzungen von Orthoamid-Derivaten mit Schwefel und Selen, Synthesen von 1,3-Thiazol- und 1,3-Selenazolderivaten
  作者：W. Kantlehner、Michael Hauber、Markus Vettel

  DOI：10.1002/prac.19963380180

  日期：——

  N,N-Dimethylformamide acetal reacts with elemental selenium to give a mixture of selenocarbonic acid derivatives 2 and 3, which can be converted to the pure N,N-dimethylcarbamidic acid Se-methylester 2 by treatment with methyl iodide. Analogously from the orthoformic acid derivatives 5 and 6 and selenium the N,N,N',N'-tetramethyl-selenurea 7 can be prepared. In the reaction of 12 with elemental sulfur and selenium the amidines 14 and 15, respectively, are formed. By treatment of 14 and 15 with alpha-halogenated carbonyl compounds and triethylamine the 1,3-thiazoles 18 and 1,3-selenazoles 19 can be prepared. The synthesis of the propynoic acid orthoamide 26b is described. 26b reacts with the guanidinium salt 24b to give the bis-orthoamide of butynedioic acid 20b. Other orthoamides of butynedioic acid 20b-20e can be synthesized from the orthoamide 20a by transamination. The thiolation of the orthoamides affords the bis-amidinium-dithiolates 21a-c, which can be alkylated to give the bis-amidinium salts 27. By treatment with alpha-halogene carbonyl compounds and triethylamine the dithiolates 21a-e are cyclized to give thieno [3,2b] thiophenes 28a-n. The quadrupoles 21 undergo cycloadditions with dimethyl-butynedioate which afford the bis(3H-thiophene-2 ylidenes) 29a-c. Treatment of 29a with methyl tosylate gives rise to the dithiophene 30a. The dithiophene 30b can be obtained by heating 21b with dimethylbutynedionate.
• Pyrazoloquinoline compounds
  申请人：Astellas Pharma Inc.

  公开号：EP2615089B1

  公开（公告）日：2016-04-27
• US7323589B2
  申请人：——

  公开号：US7323589B2

  公开（公告）日：2008-01-29
• US8822448B2
  申请人：——

  公开号：US8822448B2

  公开（公告）日：2014-09-02